Log In
Print
BCIQ
Print
Print this Print this
 

Omnaris, ciclesonide nasal spray

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionCorticosteroid aerosol nasal formulation using hydrofluoroalkane (HFA)
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRhinitis
Indication DetailsTreat seasonal allergic rhinitis (SAR)
Regulatory Designation

Partner

Dainippon Sumitomo Pharma Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today